STOCK TITAN

X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference

X4 Pharmaceuticals (NASDAQ: XFOR) said management will join a fireside chat at the Leerink Global Healthcare Conference on Wednesday, March 11, 2026 at 10:00 a.m. ET in Miami.

(Neutral)
(Very Positive)
Tags

X4 Pharmaceuticals (NASDAQ: XFOR) said management will join a fireside chat at the Leerink Global Healthcare Conference on Wednesday, March 11, 2026 at 10:00 a.m. ET in Miami. A live and archived webcast will be available on the company’s Investors site under Events and Presentations.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Mar 4 session
+5.11% close to close Open Argus
Details

News Market Reaction – XFOR

In the Mar 4 session, XFOR gained 5.11%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.1% in the session following this news. A strong positive reaction aligns with how...
Analysis

The stock moved +5.1% in the session following this news. A strong positive reaction aligns with how X4 shares have historically responded to visibility events and favorable milestones, such as the CHMP opinion that produced a +5.85% move. While this conference appearance adds investor exposure rather than new clinical data, prior patterns suggest the market can reward increased engagement. Investors have also seen prior capital markets activity under the existing S-3 shelf, which remains a structural factor when evaluating sustained upside.

Key Figures

Conference date: March 11, 2026 Chat time: 10:00 a.m. ET
Conference date
March 11, 2026
Leerink Global Healthcare Conference fireside chat
Chat time
10:00 a.m. ET
Scheduled start time of X4 fireside chat

Historical Context

5 past events · Latest: Feb 27
5 events
  1. Feb 27

    Regulatory opinion

    24h Move
    +5.8%

    CHMP positive opinion recommending EU approval of mavorixafor for WHIM.

  2. Feb 03

    Conference participation

    24h Move
    +0.5%

    Announcement of fireside chat and meetings at Guggenheim biotech summit.

  3. Feb 02

    Inducement grants

    24h Move
    +0.5%

    Inducement stock options to new employees under equity incentive plan.

  4. Nov 05

    Conference participation

    24h Move
    -1.3%

    Participation in Guggenheim healthcare innovation conference with fireside chat.

  5. Nov 05

    Earnings and update

    24h Move
    -10.6%

    Q3 2025 loss, large financings, workforce reduction, and strategy refocus.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that the management team will participate in a fireside chat at the Leerink Global Healthcare Conference on Wednesday, March 11, 2026 at 10:00 a.m. ET in Miami, FL.

A link to the live and archived webcast may be accessed on X4 Pharmaceuticals’ website under the Investors section: Events and Presentations.

About X4 Pharmaceuticals

X4 Pharmaceuticals is a company focused on improving the lives of people with rare hematology diseases by developing and commercializing innovative therapies in areas with significant unmet needs. Leveraging expertise in diseases of the immune system and CXCR4 biology, X4 has successfully developed mavorixafor, an orally available CXCR4 antagonist that is commercially available in the U.S. as XOLREMDI® in its first indication. The Company is currently conducting a global, pivotal Phase 3 clinical trial (4WARD) evaluating mavorixafor in chronic neutropenic disorders. The U.S. FDA has granted Fast Track designation to mavorixafor for the treatment of chronic neutropenia. X4 is headquartered in Boston, Massachusetts. For more information, please visit www.x4pharma.com.

X4 Investor Contact:
Remy Bernarda
Jenny Kobin
IR Advisory Solutions
ir@x4pharma.com

Source: X4 Pharmaceuticals, Inc.


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will X4 Pharmaceuticals (XFOR) present at the Leerink Global Healthcare Conference?

X4 Pharmaceuticals will present on Wednesday, March 11, 2026 at 10:00 a.m. ET. According to X4 Pharmaceuticals, management will participate in a fireside chat in Miami as part of the conference schedule and investor outreach.

How can investors watch the X4 Pharmaceuticals (XFOR) fireside chat webcast?

Investors can watch a live and archived webcast on the company website under Investors: Events and Presentations. According to X4 Pharmaceuticals, the webcast link will be posted on the Investors section for live viewing and later replay.

What is the focus of X4 Pharmaceuticals (XFOR) management at the Leerink event?

Management will participate in a fireside chat to discuss company developments and strategy. According to X4 Pharmaceuticals, the session is intended for investors and analysts to hear management perspectives on the company’s rare hematology focus.

Where is the Leerink Global Healthcare Conference held when X4 Pharmaceuticals (XFOR) presents?

The conference session takes place in Miami, Florida. According to X4 Pharmaceuticals, the fireside chat will occur at the Leerink Global Healthcare Conference venue in Miami on March 11, 2026 at 10:00 a.m. ET.

Will X4 Pharmaceuticals (XFOR) provide an archived version of the conference presentation?

Yes, an archived webcast will be available on the company website after the event. According to X4 Pharmaceuticals, both the live stream and an archived replay will be accessible under Investors: Events and Presentations.

Keep reading